Sun T, Liu B, Cai L, Zhou Y, et al. Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy. J Neurooncol 2024 Apr 23. doi: 10.1007/s11060-024-04689.
PMID: 38652401